Massachusetts-based Conagen has announced the commercial production of its 99% pure salidroside, harnessing the adaptogenic potential of the Rhodiola rosea plant through bioconversion.
Conagen is a Massachusetts-based biotechnology company that develops synthetic biology solutions for food, pharmaceutical, and renewable materials industries.